TargetRAF proto-oncogene serine/threonine-protein kinase [305-648](Homo sapiens (Human))
Bayer Pharmaceuticals Corporation
Bayer Pharmaceuticals Corporation
Affinity DataIC50: 6nMpH: 8.2 T: 2°CAssay Description:The biochemical activity of compound was determined by incubation with Raf kinases and substrate MEK-1 in the presence of 1-10 uM ATP/ [gamma-32P] AT...More data for this Ligand-Target Pair